ClinicalTrials.govpublic full text
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
acute myeloid leukaemia, mitoxantrone liposome, newly diagnosed aml patients, ara-cytarabine, azacytidine, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 841952
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.